Terazosin
- Product NDC
- 71610-503
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Substance
- TERAZOSIN HYDROCHLORIDE
- Current FDA listing
- Yes
Related Records
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|---|---|---|---|---|
| 71610-503-60 | 90 CAPSULE in 1 BOTTLE (71610-503-60) | 2020-12-08 | No | Historical | |
| 71610-503-80 | 180 CAPSULE in 1 BOTTLE (71610-503-80) | 2020-12-08 | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|---|---|---|---|
| TERAZOSIN CAPSULES, USP Rx Only | Aphena Pharma Solutions - Tennessee, LLC | 2021-01-22 | HUMAN PRESCRIPTION DRUG LABEL | 1 |